Results 151 to 160 of about 35,703 (223)

PCSK9 Inhibition

JACC: Basic to Translational Science, 2023
openaire   +1 more source

Enhanced liver-targeted delivery with ribofuranose-based GalNAc conjugates. [PDF]

Mol Ther Nucleic Acids
Pradeep SP, Ruchi R, Bahal R.
europepmc   +1 more source

HyperLp(a)lipoproteinaemia: unmet need of diagnosis and treatment? [PDF]

, 2016
Morozzi, Claudia, Stefanutti, Claudia
core   +1 more source

Genetic association between PCSK9 and coronary artery calcification mediated by inflammatory cytokines. [PDF]

Front Cardiovasc Med
Wang W, Ye J, Hu X, Chen Z, Wang L, Chen L.   +5 more
europepmc   +1 more source

PCSK9-mediated degradation of cell-surface LDL receptors impairs human CD8+ T cell effector functions. [PDF]

iScience
Markovska A, Lommers LF, Bodelón A, Greve P, van Vark-van der Zee LC, Mulder MT, Roeters van Lennep JE, Zelcer N, Schipper HS, Boes M.   +9 more
europepmc   +1 more source

Identification of a peptide inhibitor disrupting the PCSK9-LDLR interaction <i>via</i> pharmacophore-based virtual screening, molecular dynamics simulations and <i>in vitro/vivo</i> evaluation. [PDF]

J Enzyme Inhib Med Chem
Wu W, Yang S, Liu J, Wang Y, Pan D, Zhou Y.   +5 more
europepmc   +1 more source

Effects of lipid-lowering drugs on epilepsy and its subtypes: A drug-target Mendelian randomization study. [PDF]

Medicine (Baltimore)
Wang Y, Huang S.
europepmc   +1 more source

Determinants of circulating PCSK9 levels and the efficacy of PCSK9 inhibitor therapies in chronic kidney disease: a systematic review. [PDF]

Eur J Clin Pharmacol
Ábel T, Benczúr B, Csajbókné ÉC.
europepmc   +1 more source

Proprotein Convertase Subtilisin/Kexin Type 9 Induces Platelet-Derived Transforming Growth Factor-<i>β</i> to Promote Myocardial Fibrosis After Myocardial Infarction. [PDF]

Hum Mutat
Wang Q, Huang W, Xia D, Wang F, Nair S.
europepmc   +1 more source

Relationship between lipoprotein(a) and PCSK9 in angiogram-proven premature coronary artery disease in an Asian cohort. [PDF]

Sci Rep
Zulkapli R, Muid SA, Wang SM, Radzi ABM, Ibrahim KS, Mohd Yusof MYP, Nawawi H.   +6 more
europepmc   +1 more source